- ... are also observed in patients with severe congenital neutropenia. These variants are not the cause of severe congenital neutropenia, but rather arise as somatic variants and can ...
- ... management and outcomes of patients presenting with febrile neutropenia at four urban emergency departments, one of which ... audit study assessed compliance with the local febrile neutropenia protocol after heightened policy awareness and re-education ...
- ... anticipated toxicities of high-dose chemotherapy (e.g., neutropenia, thrombocytopenia, mucositis, and nausea and vomiting), they are ... rinses are often prescribed for the duration of neutropenia. The nonalcoholic chlorhexidine digluconate (0.12%–0.2%) ...
- ... factor or granulocyte-macrophage colony-stimulating factor for neutropenia; hematopoietic stem cell transplantation as indicated; immunosuppressive therapy ...
- ... prophylaxis and fever precautions in individuals with severe neutropenia. Individuals with severe neutropenia and chronic transfusion requirements, along with individuals who ...
- ... secondary prophylaxis risk stratification in episodes of febrile neutropenia oral or intravenous antibiotics growth factors in- or ... the following sections. The guideline will define febrile neutropenia/neutropenic fever and neutropenic sepsis. Population Groups that ...
- ... skeletal features (usually) Principal manifestations: exocrine pancreatic insufficiency, neutropenia, poor weight gain, & growth deficiency Multiple genes incl: ...
- ... versus higher rates of grade 3/4 infections, neutropenia, diarrhea, and neuropathy in the FLOT group. Current ... versus higher rates of grade 3/4 infections, neutropenia, diarrhea, and neuropathy in the FLOT group. In ...
- ... but diarrhea, nausea or vomiting, stomatitis, alopecia, and neutropenia were significantly less common. Of patients receiving capecitabine, ... experienced more frequent toxic effects consisting mainly of neutropenia (41% >grade 3) and reversible peripheral sensorial neuropathy ( ...
- ... over 5 years.[ 140 ] Grade 3 or higher neutropenia occurred in 32% of patients, and grade 3 ... resolved. Dose-limiting toxicities, such as neuropathy and neutropenia, may limit the overall usefulness of thalidomide. Thalidomide ...
338 results